BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34115888)

  • 1. Cancer matters: Now more than ever!
    Ramalingam SS
    Cancer; 2021 Jul; 127(13):2174-2176. PubMed ID: 34115888
    [No Abstract]   [Full Text] [Related]  

  • 2. The next age of immunotherapy: optimisation, stratification and therapeutic synergies.
    Halama N
    Br J Cancer; 2019 Jan; 120(1):1-2. PubMed ID: 30413823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has There Been a Shift in Use of Subacute Rehabilitation Instead of Hospice Referral Since Immunotherapy Has Become Available?
    Yeh JC; Knight LS; Kane J; Doberman DJ; Gupta A; Smith TJ
    J Oncol Pract; 2019 Oct; 15(10):e849-e855. PubMed ID: 31465251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating cancer with infection: a review on bacterial cancer therapy.
    Wong S; Slavcev RA
    Lett Appl Microbiol; 2015 Aug; 61(2):107-12. PubMed ID: 25963599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving synergistic combinations of targeted immunotherapies to combat cancer.
    Melero I; Berman DM; Aznar MA; Korman AJ; Pérez Gracia JL; Haanen J
    Nat Rev Cancer; 2015 Aug; 15(8):457-72. PubMed ID: 26205340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universes collide: combining immunotherapy with targeted therapy for cancer.
    Wargo JA; Cooper ZA; Flaherty KT
    Cancer Discov; 2014 Dec; 4(12):1377-86. PubMed ID: 25395294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy Approaches in Cancer Treatment.
    Klener P; Otáhal P; Lateckova L; Klener P
    Curr Pharm Biotechnol; 2015; 16(9):771-81. PubMed ID: 26087990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
    Diken M; Attig S; Grunwitz C; Kranz L; Simon P; van de Roemer N; Vascotto F; Kreiter S
    Hum Vaccin Immunother; 2013 Sep; 9(9):2025-32. PubMed ID: 23877042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for cytokine utilisation in tumor therapy.
    Di Pierro F; Cavallo F; Pericle F; Bertini S; Giovarelli M; Forni G
    Med Oncol Tumor Pharmacother; 1993; 10(1-2):53-9. PubMed ID: 8258996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity in cancer immunotherapy.
    Schietinger A; Philip M; Schreiber H
    Semin Immunol; 2008 Oct; 20(5):276-85. PubMed ID: 18684640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy.
    Liu Z; Ren Y; Weng S; Xu H; Li L; Han X
    Front Immunol; 2022; 13():809761. PubMed ID: 35140720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprogression under Immunotherapy.
    Frelaut M; Le Tourneau C; Borcoman E
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From virotherapy to oncolytic immunotherapy: where are we now?
    Coffin RS
    Curr Opin Virol; 2015 Aug; 13():93-100. PubMed ID: 26121656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [History of and novel developments in cancer immunotherapy - introduction to the special issue].
    Yamaguchi Y
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1136-9. PubMed ID: 24047770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining and managing expectations for early immunotherapy cancer trials.
    Kieber-Emmons T; Pennisi A; Lane A; Siegel E; Cannon M; Monzavi-Karbassi B; Makhoul I
    Rev Recent Clin Trials; 2015; 10(1):47-60. PubMed ID: 25723736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune gene therapy of cancer.
    Akbulut H
    Turk J Med Sci; 2020 Nov; 50(SI-2):1679-1690. PubMed ID: 32512674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted immunotherapy. An update with special emphasis on ovarian cancer.
    Maraveyas A; Epenetos AA
    Acta Oncol; 1993; 32(7-8):741-6. PubMed ID: 8305221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer immunotherapy].
    Hurtado Ruano T
    Rev Esp Oncol; 1984; 31(2):359-69. PubMed ID: 6545712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination and malignant disease: promising therapeutic approach.
    McKechnie A; Robins RA; Eremin O
    Surgeon; 2005 Jun; 3(3):224-33. PubMed ID: 16076009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.